口蹄疫疫苗市場：按疫苗類型、動物類型、地區 - 規模、份額、前景、機會分析，2022-2030

口蹄疫是一種由小核糖核酸病毒科的口蹄疫病毒引起的家畜傳染病。它主要影響牛、山羊、綿羊和豬等有蹄家畜。它通過直接和間接的感染途徑傳播。口蹄疫導致牲畜的高發病率，並由於產奶量減少、永久性蹄損傷和慢性乳腺炎而造成重大經濟損失。成年牛可以從疾病中恢復，但年幼的動物沒有很好的免疫力並且死亡率很高，因此接種口蹄疫疫苗至關重要。這種疾病的特點是發燒和舌頭、嘴唇和嘴巴上的水皰瘡。為家畜接種疫苗可以預防口蹄疫。共有七種病毒感染動物（A、O、C、SAT1、SAT2、SAT3 和 Asia1），每種毒株都會產生相似的症狀，只能通過實驗室檢測來區分。此外，世界不同地區受到不同病毒株的影響。因此，有必要使用與每種病毒株相對應的疫苗進行預防。滅活疫苗可用於預防動物感染口蹄疫。

市場動態

預計政府組織和主要參與者之間許可協議的增加將在預測期內推動全球口蹄疫疫苗市場的增長。例如，2019 年 9 月，致力於研究牲畜傳染病的研究機構 Pirbright Institute 及其研究合作夥伴宣布，提供創新獸藥和疫苗服務的組織 MSD Animal Health 已獲得足部試驗- 和口腔疾病病毒。它已授予一種新的、有效且廉價的疫苗的獨家商業許可，以保護牲畜免受多種血清型的侵害。這種疫苗從基礎科學發展到動物試驗，是牛津大學 Pirbright、雷丁大學 Diamond Light Source 和默克公司 (Merck & Co., Inc.) 的一個部門 MSD Animal Health 多年合作的結果。預計於 2022 年接手，將新技術推進到開發、註冊和製造中。

本研究的主要特點

• 本報告對全球口蹄疫疫苗市場進行了深入分析，提供了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%) .
• 解釋不同細分市場的潛在收入機會，並描述該市場具有吸引力的投資建議矩陣。
• 該研究還提供了有關市場驅動因素、抑制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、關鍵亮點、財務業績和戰略等參數，對全球口蹄疫市場的主要參與者進行概況介紹。
• 本研究涉及的主要公司包括 Agrovet Indian Immunologicals Ltd.、MSD Animal Health、Vallee SA、Bayer HealthCare、Brilliant Bio Pharma Ltd.、Intervet、Biovet、Merial、China Animal Husbandry Co., Ltd.、Biogenesis -Bago S.A、Vetal Animal Health Products S.A.VETAL Animal Health Products 和 Vecol S.A.
• 本報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• 《全球口蹄疫疫苗市場》報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
• 通過用於分析全球口蹄疫疫苗市場的各種策略矩陣，可以輕鬆做出決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第2章市場展望

• 舉報內容
  • 市場定義和範圍
• 執行摘要
  • 市場快照：按疫苗類型
  • 市場快照：按動物類型
  • 市場概況：按地區劃分
  • 舉報內容
  • 執行摘要
• 連貫的機會圖 (COM)

第 3 章市場動態、法規和趨勢分析

• 市場動態
  • 驅動程序
  • 約束因素
  • 市場機會
• 影響分析
• 新品發布
• 併購
• 監管場景
• 行業專家的推薦
• PEST 分析
• 波特五力模型
• 政府舉措
• 流行病學

第 4 章全球口蹄疫疫苗市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 整體影響
• 政府舉措
• COVID-19 對市場的影響

第 5 章全球口蹄疫疫苗市場，按疫苗類型，2017-2030 年

• 常規疫苗
• 氫氧化鋁疫苗
• 油基疫苗
• 緊急疫苗

第 6 章按動物分列的 FMD 疫苗全球市場，2017-2030 年

• 牛
• 綿羊和山羊
• 豬
• 其他

第 7 章按地區分列的全球口蹄疫疫苗市場，2017-2030 年

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海合會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第 8 章競爭格局

• Agrovet
• India Immunologicals Ltd.
• Merck Animal Health
• Shanghai Hile Bio-Pharmaceutical Co., Ltd.
• Vallee SA
• Brilliant Bio Pharma Ltd
• Merial
• China Animal Husbandry Co., Ltd.
• Biogenesis-Bago S.A.
• Vetal Animal Health Products S.A.
• Vecol S

第9章 章節

• 參考文獻
• 調查手法

Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both direct and indirect modes. Foot and mouth disease causes high morbidity in animals and results into significant economic loss due to decreased milk production, permanent hoof damage, and chronic mastitis. Although adult animals can recover from the disease, mortality is high among young animals, as immunity is not well developed due to which foot and mouth disease vaccination is essential. The disease is characterized by fever and blistery sore on tongue, lips and oral cavity. Foot and mouth disease is best preventable by vaccinating the livestock. There are total seven strains (A, O, C, SAT1, SAT2, SAT3, and Asia1) of the virus that affect animals, symptoms produced are similar in each strain and they can be distinguished only through laboratory tests. Various regions around the world are affected by different set of viral strains. Therefore each strain requires specific vaccine to prevent the infection. Inactivated vaccines are available to prevent animals from being infected by foot and mouth disease.

Market Dynamics

Increasing licensing agreements between government organization and key players are expected to drive market growth of the global foot and mouth disease vaccine market over the forecast period. For instance, in September 2019, Pirbright Institute, a research institute dedicated to the study of infectious diseases of farm animals, and its research partners had granted MSD Animal Health, the organizational company that offers innovative veterinary pharmaceuticals and vaccines services, an exclusive commercial licence for a new, effective, and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus. The vaccine has been developed from basic science to animal trials as a result of long-standing collaborations between Pirbright, the University of Oxford, Diamond Light Source, the University of Reading, and MSD Animal Health, a division of Merck & Co., Inc., who will be taken in 2022 forward the new technology into development, registration and manufacturing.

Key features of the study:

• This report provides an in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Agrovet Indian Immunologicals Ltd., MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogenesis-Bago S.A, Vetal Animal Health Products S.A.VETAL Animal Health Products, and Vecol S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation:

• Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:
  • Conventional Vaccine
  • Aluminum Hydroxide based vaccine
  • Oil based vaccines
  • Emergency Vaccines
• Global Foot and Mouth Disease Vaccine Market, By Animal Type:
  • Cattle
  • Sheep and Goat
  • Swine
  • Others
• Global Foot and Mouth Disease Vaccine Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Agrovet*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • India Immunologicals Ltd.
  • Merck Animal Health
  • Shanghai Hile Bio-Pharmaceutical Co., Ltd.
  • Vallee SA
  • Brilliant Bio Pharma Ltd
  • Merial
  • China Animal Husbandry Co., Ltd.
  • Biogenesis-Bago S.A.
  • Vetal Animal Health Products S.A.
  • Vecol S

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Vaccine Type
  • Market Snapshot, By Animal Type
  • Market Snapshot, By Region
  • Report Description
  • Executive Summary
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• New Product Launches
• Mergers and Acquisitions
• Regulatory Scenario
• Testimonials from Industry Expert
• PEST Analysis
• Porters Five Forces model
• Government Initiative
• Epidemiology

4. Global Foot and Mouth Disease Vaccine Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Foot and Mouth Disease Vaccine Market , By Vaccine Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Conventional Vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Aluminum Hydroxide based vaccine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Oil based vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Emergency Vaccines
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Foot and Mouth Disease Vaccine Market , By Animal Type , 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Cattle
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Sheep and Goat
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Swine
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Foot and Mouth Disease Vaccine Market , By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• UK
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Animal Type , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

8. Competitive Landscape

• Agrovet*
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• India Immunologicals Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merck Animal Health
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Shanghai Hile Bio-Pharmaceutical Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vallee SA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Brilliant Bio Pharma Ltd
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Merial
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• China Animal Husbandry Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Biogenesis-Bago S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vetal Animal Health Products S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Vecol S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Section

• References
• Research Methodology
• About Us and Sales Contact